Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1Phase 3 1

Status

Completed 2Recruiting 1

Sponsor Class

OTHER 3

Study Type

Observational 5Interventional 3

Sponsor

Cancer Type

Lymphoid 1Head & Neck 1Dermatologic 1

Conditions

Thyroid Neoplasms 1Polycystic Ovary Syndrome 1Menstruation Disturbances 1Lymphoma, T-Cell, Cutaneous 1Hypertriglyceridemia 1Hyperthyroidism 1Graves Disease 1

Interventions

Cyclophosphamide 3155Cisplatin 3151Carboplatin 2929Paclitaxel 2671Radiotherapy 2643Gemcitabine 2544pembrolizumab 2324Docetaxel 2154Bevacizumab 2126Fluorouracil 1819Capecitabine 1780Oxaliplatin 1709Dexamethasone 1589Nivolumab 1516Doxorubicin 1477Rituximab 1453Etoposide 1341Magnetic Resonance Spectroscopy 1261Irinotecan 1232Leucovorin 1212Cytarabine 1123Pemetrexed 1060Drug Therapy 1060fludarabine 1044Vincristine 956Specimen Handling 928Prednisone 924Cetuximab 919Lenalidomide 916Trastuzumab 897

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Glucose Tolerance Test × Clear all
NCT07410637 2026-02-13

Impact of Thyroid Hormones on Human Glucose and Energy Metabolism

University of Ulm

Phase NA Recruiting
60 enrolled
Head & Neck

Graves Disease, Hyperthyroidism, Thyroid Neoplasms

NCT01569724 2017-07-21

TgBEX

Rennes University Hospital

Phase 4 Completed
10 enrolled
DermatologicLymphoid

Hypertriglyceridemia, Lymphoma, T-Cell, Cutaneous

NCT00283816 2015-05-15

Impact of Metformin in Teens With Polycystic Ovary Syndrome (PCOS) on Oral Contraceptive Therapy

University of Rochester

Phase 3 Completed
36 enrolled 9 charts

Menstruation Disturbances, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡